Q2 revenue rose to NOK 727m (from NOK 570m), up 27% year-on-year, alongside Q2 diluted EPS of NOK 0.24 vs NOK 0.18. For H1, revenue increased to NOK 1,140m (from NOK 977m) and diluted EPS to NOK 0.32 (from NOK 0.27). Management cited accelerating momentum and particular improvement in Corporate Financing, with capital markets remaining supportive.
The clean read-through is not “good quarter,” but that the fee pool for Nordic capital-markets platforms is reopening faster than consensus likely assumed. That supports operating leverage because these businesses tend to have a relatively fixed cost base while advisory/financing volumes swing sharply, so incremental revenue converts disproportionately into earnings and near-term multiple support.
The second-order effect is competitive: if capital markets stay open, the gain doesn’t just accrue to this firm — it also widens the playing field for smaller ECM/DCM and corporate-finance boutiques that can underwrite mid-market issuance faster than universal banks. The risk is that this is timing-driven rather than structural; a few large mandates can make a quarter look durable, but the revenue base can normalize quickly if volatility, rates, or credit spreads turn less friendly.
Over 1-3 months, the key catalyst is whether management can show pipeline conversion rather than just a better quarter. Over 6-18 months, the debate is whether this becomes a higher-ROE, less cyclical franchise or remains a high-beta proxy for deal activity. The contrarian view is that the market may be underestimating fee competition: when activity rebounds, pricing power often erodes before volumes do, so margin expansion can lag headline revenue growth.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.35
